Skip to main content
Brii Biosciences Limited logo

Brii Biosciences Limited — Investor Relations & Filings

Ticker · 2137 LEI · 5493000GCQ47MM4EKK44 HKEX Manufacturing
Open in API
Filings indexed 278 across all filing types
Latest filing 2026-04-26 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 2137

About Brii Biosciences Limited

http://www.briibio.com

Brii Biosciences Limited is a biotechnology company focused on developing therapies to address significant public health challenges. The company specializes in advancing first-in-class and/or different-in-class treatment options, primarily targeting infectious diseases and central nervous system diseases. Brii Bio concentrates its development efforts on therapeutic areas characterized by high unmet medical needs, social stigmas, and limited existing treatment options. Through scientific innovation and critical patient insights, the company is building an extensive pipeline designed to deliver differentiated therapeutic solutions.

Recent filings

Filing Released Lang Actions
VOLUNTARY ANNOUNCEMENT Presents Cross-Study Analysis of Post-Treatment HBsAg Rebound at APASL 2026
Regulatory Filings Classification · 1% confidence The document is a voluntary announcement filed on the Hong Kong Exchange announcing the Company’s scientific cross-study analysis presentation at a medical conference (APASL 2026). It contains no financial results, no change in management or board, no capital or dividend update, and is not a standalone financial report or detailed investor slide deck. It does not request votes nor provide proxy materials. Thus it does not fit any specific category except the general fallback “Regulatory Filings (RNS).”
2026-04-26 English
Notification Letter and Request Form for Non-registered Shareholders
Report Publication Announcement Classification · 1% confidence The document is a notification letter to non-registered shareholders informing them that the 2025 Annual Report, Circular, Notice of Annual General Meeting and Proxy Form, and 2025 ESG Report have been published online, and provides instructions to request printed copies. It does not contain the reports themselves or substantive financial data, but rather announces their availability. This fits the definition of a Report Publication Announcement.
2026-04-23 English
Notification Letter and Change Request Form for Registered Shareholders
Report Publication Announcement Classification · 1% confidence The document is a corporate notification letter informing shareholders that the 2025 Annual Report, Circular, Notice of Annual General Meeting, Proxy Form, and 2025 ESG Report have been published online and providing instructions for requesting printed or electronic copies. It does not contain the financial statements themselves, nor detailed report content, but simply announces the publication and access methods. This matches the definition of a Report Publication Announcement (RPA).
2026-04-23 English
2025 Environmental, Social and Governance Report
Regulatory Filings
2026-04-23 English
FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING
AGM Information Classification · 1% confidence The document is a Form of Proxy for use at the Annual General Meeting of BriB Biosciences Limited. It provides proxy appointment instructions and voting resolutions for the AGM, clearly indicating it is material related to the Annual General Meeting rather than an earnings release, report or other filing. Therefore, it falls under AGM Information (AGM-R).
2026-04-23 English
(1) PROPOSALS FOR ADOPTION OF THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS; (2) RE-ELECTION OF RETIRING DIRECTORS; (3) RE-APPOINTMENT OF AUDITOR; (4) GENERAL MANDATES TO ISSUE AND BUY-BACK SHARES; AN
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a shareholder circular for Brii Biosciences Limited requesting votes on AGM resolutions (adoption of audited financial statements, re-election of directors, reappointment of auditor, share issue/buy-back mandates) and includes a notice of the Annual General Meeting and a form of proxy. It is distributed to solicit proxies and inform shareholders about meeting proposals rather than being the financial report itself, matching the definition for a Proxy Solicitation & Information Statement (PSI).
2026-04-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.